Skip to contentU
Ultralife Corp
U
ULBIUltralife Corp Q2 2024 · 10-Q
Revenue$42.98M$42.98M+0.7% vs Q2 2023 Net Income$2.97M$2.97M−11.1% vs Q2 2023 EPS Diluted$0.18$0.18+500.0% vs Q2 2023 Gross Profit$11,563,000+9.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ultralife Corp · CIK 875657 · Engraved from SEC EDGAR
Operating Cash Flowderived$8,925,000+409.7% Free Cash Flowderived$8,565,000+593.5% Margins · derivedGross margin26.9%+2.1 pt vs Q2 2023
Operating margin9.1%+0.5 pt vs Q2 2023
Net margin6.9%−0.9 pt vs Q2 2023
ended Jun 30, 2024 · filed Jul 25, 2024 · 25 d after period end